HR 3852 RDS
(7) 5 nongovernmental experts in drug abuse
prevention and treatment to be selected by the At-
torney General.
(b) RESPONSIBILITIES.—The interagency task force
shall be responsible for designing, implementing, and eval-
uating the education and prevention and treatment prac-
tices and strategies of the Federal Government with re-
spect to methamphetamine and other synthetic stimulants.
(c) MEETINGS.—The interagency task force shall
meet at least once every 6 months.
(d) FUNDING.—The administrative expenses of the
interagency task force shall be paid out of existing Depart-
ment of Justice appropriations.
(e) FACA.—The Federal Advisory Committee Act (5
U.S.C. App. 2) shall apply to the interagency task force.
(f) TERMINATION.—The interagency task force shall
terminate 4 years after the date of enactment of this Act.
SEC. 502. PUBLIC HEALTH MONITORING.
The Secretary of Health and Human Services shall
develop a public health monitoring program to monitor
methamphetamine abuse in the United States. The pro-
gram shall include the collection and dissemination of data
related to methamphetamine abuse which can be used by
public health officials in policy development.
HR 3852 RDS
SEC. 503. PUBLIC-PRIVATE EDUCATION PROGRAM.
(a) ADVISORY PANEL.—The Attorney General shall
establish an advisory panel consisting of an appropriate
number of representatives from Federal, State, and local
law enforcement and regulatory agencies with experience
in investigating and prosecuting illegal transactions of
precursor chemicals. The Attorney General shall convene
the panel as often as necessary to develop and coordinate
educational programs for wholesale and retail distributors
of precursor chemicals and supplies.
(b) CONTINUATION
OF CURRENT EFFORTS.—The
Attorney General shall continue to—
(1) maintain an active program of seminars and
training to educate wholesale and retail distributors
of precursor chemicals and supplies regarding the
identification of suspicious transactions and their re-
sponsibility to report such transactions; and
(2) provide assistance to State and local law en-
forcement and regulatory agencies to facilitate the
establishment and maintenance of educational pro-
grams for distributors of precursor chemicals and
supplies.
SEC. 504. SUSPICIOUS ORDERS TASK FORCE.
(a) IN GENERAL.—The Attorney General shall estab-
lish a ‘‘Suspicious Orders Task Force’’ (the ‘‘Task
Force’’) which shall consist of—
HR 3852 RDS
(1) appropriate personnel from the Drug En-
forcement Administration (the ‘‘DEA’’) and other
Federal, State, and local law enforcement and regu-
latory agencies with the experience in investigating
and prosecuting illegal transactions of listed chemi-
cals and supplies; and
(2) representatives from the chemical and phar-
maceutical industry, including representatives from
the DEA/Distributor Working Committee and the
DEA/Pharmacy Working Committee.
(b) RESPONSIBILITIES.—The Task Force shall be re-
sponsible for developing proposals to define suspicious or-
ders of listed chemicals, and particularly to develop quan-
tifiable parameters which can be used by registrants in
determining if an order is a suspicious order which must
be reported to DEA. The quantifiable parameters to be
addressed will include frequency of orders, deviations from
prior orders, and size of orders. The Task Force shall also
recommend provisions as to what types of payment prac-
tices or unusual business practices shall constitute prima
facie suspicious orders. In evaluating the proposals, the
Task Force shall consider effectiveness, cost and feasibil-
ity for industry and Government, an other relevant fac-
tors.
HR 3852 RDS
(c) MEETINGS.—The Task Force shall meet at least
two times per year and at such other times as may be
determined necessary by the Task Force.
(d) REPORT.—The Task Force shall present a report
to the Attorney General on its proposals with regard to
suspicious orders and the electronic reporting of sus-
picious orders within one year of the date of enactment
of this Act. Copies of the report shall be forwarded to the
Committees of the Senate and House of Representatives
having jurisdiction over the regulation of listed chemical
and controlled substances.
(e) FUNDING.—The administrative expenses of the
Task Force shall be paid out of existing Department of
Justice funds or appropriations.
(f) FACA.—The Federal Advisory Committee Act (5
U.S.C. App. 2) shall apply to the Task Force.
(g) TERMINATION.—The Task Force shall terminate
upon presentation of its report to the Attorney General,
or two years after the date of enactment of this Act,
whichever is sooner.
Passed the House of Representatives September 26,
1996.
Attest:
ROBIN H. CARLE,
Clerk.